Salix Pharmaceuticals, Ltd. (NASDAQ:SLXP)
CAPS Rating:
A pharmaceutical company dedicated to acquiring, developing and commercializing prescription drugs used in the treatment of a variety of gastrointestinal diseases, which are those affecting the digestive tract.
RSS Headlines
Fool UK
Recs
I don't pay much attention to analyst upgrades usually, but this got one recently and already had a PEG ratio of only 0.58, so the added publicity could be going where it will actually help investors.